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Abstract 
Review on SGK1, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: SGK 
HGNC (Hugo): SGK1 
Location: 6q23.2 
DNA/RNA 
Description 
The SGK1 gene is comprised of 14 coding exons 
(Ensembl). 
Transcription 
Sgk1 contains 28 distinct gt-ag introns, it presents 32 
different mRNAs transcription products with 28 
alternatively spliced variants and 4 unspliced forms. 
8 probable alternative promoters have been 
identified, 10 non overlapping alternative last exons 
and 8 validated alternative polyadenylation sites  
(AceView).  
The SGK1 gene is conserved in chimpanzee, Rhesus 
monkey, dog, cow, mouse, rat, chicken, zebrafish, 
and C. elegans (Gene ID: 6446, NCBI). 
Protein 
Note 
The serum- and glucocorticoid-inducible kinase 1 
(SGK1) was discovered as a gene regulated 
transcriptionally by serum- and glucocorticoids in rat 
mammary tumor cells (Firestone et al., 2003). 
Description 
SGK1 is a member of the "AGC" subfamily (García 
Martínez and Alessi, 2008). SGK1 activation is 
dependent on phosphorylation. mTOR was found to 
be the H-motif kinase that phosphorylates Sgk1 at 
S422 and PDK1 at T256 (Hong et al., 2008; Amato 
et al., 2007; Kobayashi and Cohen, 1999; Perrotti et 
al., 2001). Sgk1 is involved in mediating growth 
factor-, insulin-, IL-2- and steroid-dependent 
survival signals (Lang et al., 2009a; Mikosz et al., 
2001). 
Chain (1-431) serine/threonine-protein kinase Sgk1; domain (98-355) protein kinase; domain (366-431) AGC-kinase C-terminal 
(UNIPROT). 
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Expression 
SGK1 transcription is regulated by the 
glucocorticoid receptor (GR), the mineralocorticoid 
receptor (MR), the progesterone receptor (PR), the 
vitamin D receptor (VDR), the retinoid X receptor 
(RXR), the farnesoid X receptor (FXR), the sterol 
regulatory element binding protein (SREBP), 
peroxisome proliferator-activated receptor γ 
(PPARγ), the cAMP response element binding 
protein (CREB), the p53 tumor suppressor protein, 
the Sp1 transcription factor, the activating protein 1 
(AP1), the activating transcription factor 6 (ATF6), 
the heat shock factor (HSF), reticuloendotheliosis 
viral oncogene homolog (c-Rel), nuclear factor κB 
(NFκB), signal transducers and activators of 
transcription (STAT), TGFβ dependent transcription 
factors SMAD3 and SMAD4, and fork-head activin 
signal transducer (FAST) (Lang et al., 2009a). 
Localisation 
SGK presents a stimulus-dependent regulation for 
the subcellular localization. SGK actively shuttles 
between the nucleus (in S and G2/M) and the 
cytoplasm (in G1) in synchrony with the cell cycle 
(Buse et al., 1999). The nuclear localization signal 
(NLS) of SGK (located at an external surface of the 
molecule) binds the importin-alpha nuclear import 
receptor regulating the nuclear-cytoplasmic shuttling 
(Firestone et al., 2003). 
SGK-1 localizes in the mitochondria, under 
hyperosmotic stress, that permits access to 
physiologically appropriate mitochondrial 
interacting proteins and substrates, such as IF-1 and 
the F1F0-ATPase, as part of the cellular stressed 
induced program (O'Keeffe et al., 2013). 
A significant fraction of SGK-1 is membrane-
associated and ubiquitilated (Brickley et al., 2002). 
Function 
SGK1 regulates different ion channels, transporters, 
transcription factors and enzyme: ion channels like 
ENaC (Faletti et al., 2002), TRPV5, ROMK, Kv1.3, 
KCNE1/KCNQ1, GluR1, GluR6; carriers like 
NHE3, GLUT1, SGLT1, EAAT1, EAAT2, EAAT3, 
EAAT4, EAAT5, Na+-K+-ATPase. SGK1 regulates 
the activity of enzymes like glycogen synthase 
kinase-3, ubiquitin ligase Nedd4-2, 
phosphomannomutase-2 and transcription factors 
like forkhead transcription factor FKHRL1, beta-
catenin, nuclear factor kappaB. Moreover, SGK1 
contributes to the regulation of transport, hormone 
release, neuroexcitability, cell proliferation, and 
apoptosis (Lang et al., 2006). 
Sgk1 can phosphorylate and activate MDM2, 
driving p53 to degradation, protecting cells from 
stress dependent apoptosis (Amato et al., 2009). 
Sgk1 was demonstrated to interact with 
phosphomannomutase 2 (PMM2), inhibiting its 
activity, with and without insulin stimulus (Menniti 
et al., 2005).  
Moreover, it was demonstrated that the 60 kDa 
Lysophospholipase (LysoLP) interacts with SGK1, 
and that the expression of LysoLP in Xenopus 
oocytes decreases membrane expression of ENaC, 
inhibiting basal and Sgk1-dependent activation of 
the channel (Menniti et al., 2010). Sgk1 can 
regulates RANBP1 at the gene transcription level 
with functional consequences on microtubule 
stability and cell sensitivity to taxol (Amato et al., 
2013). 
Alternative initiation of transcription at -2981, -850 
upstream of the transcription initiation site (+1) of 
the reference mRNA of SGK1 was studied. 
Transcription of three distinct splice variants are all 
markedly upregulated in tumor tissues but 
differentially up-regulated under differentiation or 
hypoxia. 
Implicated in 
Various cancers 
Increased expression of SGK1 have been observed 
in colon cancer, myeloma, medulloblastoma, 
prostate cancer, ovarian tumors and non-small cell 
lung cancer (Lang et al., 2013).  
SGK1-sensitive implication in tumour growth 
include activation of K(+) channels and Ca(2+) 
channels, Na(+)/H(+) exchanger, amino acid 
transporters, glucose transporters, upregulation of 
the nuclear factor NFkappaB and beta-catenin and 
downregulation of the transcription factors 
Foxo3a/FKHRL1 and p53 (Lang et al., 2010).  
SGK1 phosphorylates MDM2 with consequent p53 
ubiquitylation, and influences cell proliferation, 
survival, and differentiation (Amato et al., 2009).  
In cancer cells, SGK1 up-regulates RanBP1, a major 
effector of the GTPase RAN, which in turn 
influences mitotic microtubule activity and 
decreases taxol sensitivity (Amato et al., 2013). 
SGK1 expression mediated the phosphorylation of 
ERK2, then the MEK/ERK complexes formation 
during liver regeneration (Won et al., 2009). 
SGK1 negatively regulates stress-activated signaling 
through inhibition of SEK1 function (Kim et al., 
2007). 
SGK1 interferes with the binding of SEK1 to JNK1 
and MEKK1 (Lang et al., 2010), down-regulates 
vinculin phosphorylation, which in turn may 
enhance migration via actin cytoskeleton 
redistribution (Schmidt et al., 2012). 
SGK1 influences the activity of channels and 
transporters, such as Ca2+ release-activated 
channels (ICRAC) Orai1/STIM (Eylenstein et al., 
2012) and the K+ channel Kv1.3, influencing cell 
proliferation and cell death (Schmidt et al., 2012). 
SGK1 is a direct beta-catenin target gene and in 
colon cancer cells its up-regulation determines a 
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decrease of apoptosis through the down-regulation 
of Foxo3a activity (Dehner et al., 2008).  
SGK-1 has significant homology with the serine-
threonine Akt which is considered a relevant player 
in carcinogenesis, since its activation occurred in the 
majority of human tumors. Interestingly, some 
cancer cell lines that are resistant to Akt inhibition 
showed significant up-regulation of SGK1 
expression (Sommer et al., 2013). 
Colorectal carcinoma 
A recent study confirms the sensitivity of colon 
carcinoma to the expression of SGK1. Following 
deficiency of APC (adenoma polyposis coli) or 
chemical cancerogenesis, SGK1 knockout mice 
develop less intestinal tumours than their wild-type 
littermates and pharmacological SGK1 inhibition 
counteracts growth of cancer cells (Lang et al., 
2010). SGK1 up-regulates RanBP1, a major effector 
of the GTPase RAN, which in turn influences mitotic 
microtubule activity and decreases taxol sensitivity 
in RKO colon carcinoma cells (Amato et al., 2013). 
Kidney cancer 
In A-498 kidney cancer cells, IL-2 binding to its own 
receptor triggers a signal transduction pathway 
leading to the inhibition of proliferation and 
apoptosis. Inhibition of proliferation is associated 
with Erk1/2 dephosphorylation, whereas the survival 
signals appear to be mediated by Sgk1 activation 
(Amato et al., 2007). 
Myeloma 
SGK1 is a highly cytokine-responsive gene in 
myeloma cells promoting their malignant growth. 
Fagerli et al. recently have demonstrated a rapid, 
strong and sustained induction of SGK1 in primary 
myeloma cells. Inhibition of the Janus kinase/signal 
transducer and activator of transcription 
(JAK/STAT) pathway abolished STAT3 
phosphorylation and SGK1 induction. 
Downregulation of SGK1 by shRNAs resulted in 
decreased proliferation of myeloma cell lines, with 
induction of cell cycle inhibitory genes, like 
CDKNA1/p21, and downregulation of CDK6 and 
RBL2/p130 (Fagerli et al., 2011). 
Prostate cancer 
Rauhala et al. showed the downregulation of mRNA 
and protein expressions of SGK, in prostate cancer. 
The expression of SGK was decreased in about half 
of the prostate carcinomas, whereas the expression 
was high in all non-malignant prostate epithelial 
cells (Rauhala et al., 2005).  
Low espression of SGK1 is associated with higher 
tumor grade and increased cancer recurrence, and is 
a potential indicator of aberrant androgen receptor 
signaling. Glucocorticoid receptor expression 
increased with androgen deprivation, potentially 
providing a mechanism for the maintenance of 
androgen pathway signaling in these tumors 
(Szmulewitz et al., 2012). 
Inhibition of SGK1 expression or activity 
antagonizes androgen-induced growth of the 
prostate cancer cell line LNCaP, suggesting that 
SGK1 might be a viable target for the treatment of 
prostate cancer (Sherk et al., 2008). 
Ovarian cancer 
Sgk was identified like a critical FSH-regulated gene 
important for the proliferation and maturation of 
granulosa cells in the normal ovary (Richards, 1994). 
Specific and reproducible gene expression changes 
occur in human ovarian tumors over time, following 
systemic administration of glucocorticoids. 
Induction of SGK1 gene expression in epithelial 
tumor cell lines inhibits chemotherapy-induced 
tumor cell apoptosis (Melhem et al., 2009). 
Sgk expression is lower in epithelial tumours, serous 
and mucinous cystadenocarcinomas, and also in 
normal pre-menopausal ovaries (Chu et al., 2002). 
Hypertension 
There are different SGK1 gene variants that can 
influence blood pressure (Rao et al., 2013), including 
the combination of polymorphisms in intron 6 
[I6CC] and exon 8 [E8CC/CT] (Lang et al., 2006; 
Lang et al., 2009a).  
The insulin probably stimulates renal tubular salt 
reabsorption through the activation of SGK1 with 
consequent renal salt retention and hypertension in 
type II diabetes (Lang et al., 2006; Lang et al., 
2009a). 
Diabetes 
SGK1 regulates the Na+ coupled glucose transporter 
SGLT1 (Lang et al., 2006), the adipocyte 
differentiation and the adipogenesis (Di Pietro et al., 
2010). The I6CC/E8CC/CT SGK1 gene variant 
determines enhancement in body weight and 
prevalence of type 2 diabetes (Lang et al., 2009b). 
Thrombosis 
SGK1 stimulates coagulation, through tissue factor 
expression (Lang et al., 2009a) and regulation of 
blood platelets by up-regulation of NFκB, and 
consequent expression of the platelet Ca2+ channel 
Orai1/STIM1, that predisposing to stroke (Dahlberg 
et al., 2011) and thrombosis (Borst et al., 2012). 
Autoimmune disease 
SGK1 is involved in autoimmune disease, through 
up-regulation of the pathogenic IL-23-dependent 
interleukin (IL) 17-producing CD4+ helper T cells 
(TH17 cells) (Kleinewietfeld et al., 2013).  
In affected tissues of inflammatory and fibrosing 
diseases was demonstrated an excessive expression 
of SGK1, like in lung fibrosis, diabetic nephropathy, 
glomerulonephritis, experimental nephrotic 
syndrome, obstructive nephropathy, liver scirrhosis, 
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fibrosing pancreatitis, peritoneal fibrosis, Crohn’s 
disease, and coeliac disease (Cheng et al., 2010; 
Lang et al., 2006; Yamahara et al., 2009). 
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